Family Medicine Doctors in Mountain Home, ID Accepting Medicare
9 Family Medicine doctors found. Showing 1 - 9
 Scott Alan Baldridge, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 365 Mckenna Dr, Mountain Home, ID 83647 Phone: 208-587-9703 |
Stephen C Johnson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 895 N 6th E, Mountain Home, ID 83647 Phone: 702-453-3799 Fax: 702-453-5741 |
 Katherine Gray, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Desert Sage Way, Mountain Home, ID 83647 Phone: 208-875-3988 Fax: 208-587-3324 |
Dr. Karl H. Olson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 465 Mckenna Dr, Mountain Home, ID 83647 Phone: 208-587-9703 Fax: 208-580-9812 |
Dr. Dennis Dan Crossley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 465 Mckenna Dr, Mountain Home, ID 83647 Phone: 208-587-9703 Fax: 208-580-9812 |
Scott K M Knudsen, Family Medicine Medicare: Medicare Enrolled Practice Location: 120 Desert Sage Way, Mountain Home, ID 83647 Phone: 208-587-3988 |
Timothy James Muhonen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 465 Mckenna Dr, Mountain Home, ID 83647 Phone: 208-587-9703 |
Dr. Richard Frederick Starkey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 805 N 6th E, Mountain Home, ID 83647 Phone: 208-587-9736 Fax: 208-587-7905 |
Dr. Layne D. Roberts, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 American Legion Blvd, Mountain Home, ID 83647 Phone: 208-587-1500 Fax: 208-587-3180 |
News Archive
Researchers report no increased rate of heart attack in patients taking rosiglitazone
The diabetes drug rosiglitazone has been under intense scrutiny since a 2007 study in the New England Journal of Medicine looked at more than 40 clinical trials and linked the drug's use with increased risk of heart attack and death from heart disease.
Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors
Infinity Pharmaceuticals, Inc. today announced promising preliminary results from a Phase 1 study of IPI-926, its novel, oral small molecule that targets the Hedgehog pathway.
Adult brain cells revert back to embryonic state after injury, study finds
When adult brain cells are injured, they revert to an embryonic state, according to new findings published in the April 15, 2020 issue of Nature by researchers at University of California San Diego School of Medicine, with colleagues elsewhere.
NanoString to begin clinical development program for Breast Cancer Intrinsic Subtyping Assay
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it is initiating the first in a series of studies to evaluate the clinical utility of the NanoString Breast Cancer Intrinsic Subtyping Assay.
CRC Health Corporation second quarter 2010 net revenue increases 5.3%
CRC Health Corporation, a leading provider of substance abuse treatment and adolescent youth services through its wholly owned consolidated subsidiaries, announced its results for the three months and six months ended June 30, 2010.
› Verified 6 days ago